Next |
home / stock / bivi / bivi message board
Subject | By | Source | When |
---|---|---|---|
$BIVI are we finally gonna see some action | TheFinalCD | investorshub | 06/24/2023 6:10:56 PM |
$BIVI Price trading | duderaja | investorshub | 06/23/2023 1:14:59 PM |
Good read | akamaii | investorshub | 06/21/2023 1:02:47 AM |
MomentumIts trading | 02opida | investorshub | 06/18/2023 8:30:10 PM |
The now | subslover | investorshub | 06/17/2023 1:17:54 AM |
The trading up | 02opida | investorshub | 06/11/2023 7:12:55 PM |
best news of the day | McMagyar | investorshub | 06/11/2023 3:14:40 AM |
$BIVI The now last trade up | hedge_fun | investorshub | 06/10/2023 12:10:08 PM |
$BIVI MomentumIts now last up | TheFinalCD | investorshub | 06/10/2023 4:22:42 AM |
Smell news coming | akamaii | investorshub | 06/10/2023 2:24:31 AM |
$BIVI Have a look at this | noretreat | investorshub | 06/09/2023 4:33:37 AM |
$BIVI Do we have a winner?Turn around time? | noretreat | investorshub | 06/06/2023 11:01:40 AM |
Adding | akamaii | investorshub | 06/05/2023 12:14:43 AM |
The gaining up | TheFinalCD | investorshub | 06/03/2023 7:51:44 PM |
Have a look at this | Crapola2theleft | investorshub | 06/02/2023 3:40:11 AM |
$BIVI Price trading last trade up | 02opida | investorshub | 06/01/2023 9:49:54 AM |
MomentumIts gaining | McMagyar | investorshub | 05/31/2023 11:32:59 PM |
$BIVI The trading last up | 02opida | investorshub | 05/31/2023 12:45:01 PM |
MomentumIts trading last trade up | noretreat | investorshub | 05/30/2023 7:46:44 AM |
and the shorts continue | 02opida | investorshub | 05/30/2023 7:00:52 AM |
News, Short Squeeze, Breakout and More Instantly...
BioVie Inc. Company Name:
BIVI Stock Symbol:
OTCMKTS Market:
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...
Increasing evidence supports a role for viral persistence, chronic inflammation and immune and metabolic dysregulation in driving long COVID Bezisterim, an anti-inflammatory and insulin-sensitizer that permeates the blood brain barrier, could represent a novel oral treatment targeting a...